Get started
Author

Zhuo‐Chen Cai

Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy
2022 · Guo-Ying Liu, Wang-Zhong Li, et al. · JAMA Oncology · 52
CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling
2022 · Dongni Chen, Hongli Zhou, et al. · Journal of Experimental & Clinical Cancer Research · 45
PDF
An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features
2021 · Xi Chen, Yingxue Li, et al. · Oral Oncology · 41
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2021 · Wei-Xiong Xia, Xing Lv, et al. · Clinical Cancer Research · 34
Anxiety and depression in nasopharyngeal carcinoma patients and network analysis to identify central symptoms: A cross-sectional study from a high-incidence area
2024 · Ze-Jiang Zhan, Hao-Yang Huang, et al. · Radiotherapy and Oncology · 22
PDF
Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis
2022 · Zhuochen Cai, Dongni Chen, et al. · Journal of Cancer Research and Clinical Oncology · 15
PDF
The Prognostic Impact of Combined Tumor-Infiltrating Lymphocytes and Pretreatment Blood Lymphocyte Percentage in Locally Advanced Nasopharyngeal Carcinoma
2022 · Zhuochen Cai, Jiali Jiang, et al. · Frontiers in Oncology · 13
PDF
Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma
2023 · Xi Chen, Ying-xue Li, et al. · Lipids in Health and Disease · 10
PDF
Prognostic significance of cervical radiologic carotid artery invasion by lymph node on magnetic resonance imaging in nasopharyngeal carcinoma
2023 · Wenze Qiu, Xi Zhong, et al. · Cancer Imaging · 9
PDF
An Individualized Prognostic Model in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Based on Serum Metabolomic Profiling
2023 · Jiayu Zhou, Yishu Deng, et al. · Life · 8
PDF
Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma
2020 · Xi Chen, Xun Cao, et al. · Frontiers in Oncology · 8
PDF
Incidence, consequences, and predictors of serious chemotherapy‐induced thrombocytopenia in nasopharyngeal carcinoma
2023 · Lu‐Lu Zhang, Xi Chen, et al. · Cancer Medicine · 6
PDF
Short‐term efficacy and long‐term survival of nasopharyngeal carcinoma patients with radiographically visible residual disease following observation or additional intervention: A real‐world study in China
2022 · Ying‐Ying Huang, Xun Cao, et al. · Laryngoscope Investigative Otolaryngology · 6
PDF
Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose
2023 · Ying-Ying Huang, Jia-Yu Zhou, et al. · BMC Cancer · 4
PDF
Integrated strategies for chemotherapy cycles in nasopharyngeal carcinoma patients: Real-world data from two epidemic centers guiding decision-making
2023 · Zejiang Zhan, Yingying Huang, et al. · Chinese Journal of Cancer Research · 4
Add-on individualizing prediction of nasopharyngeal carcinoma using deep-learning based on MRI: A multicentre, validation study
2022 · Xun Cao, Xi Chen, et al. · iScience · 4
Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma
2024 · Jiali Jiang, Zhuochen Cai, et al. · European Archives of Oto-Rhino-Laryngology
FigureS1 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
FigureS2 from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
PDF
Supplementary Data from A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
2023 · Wei-Xiong Xia, Xing Lv, et al.
Works count: 29
Citation count: 281
H-index: 9
I10-index: 8
Year
Topic
Type